58 related articles for article (PubMed ID: 34174799)
1. Serum antiganglioside antibodies in patients with autoimmune limbic encephalitis.
Oktar AÇ; Selçuk Ö; Tunç CE; Işıldak Ş; Şanlı E; Yılmaz V; Tüzün BB; Kürtüncü M; Çokar AÖ; Tüzün E
Turk J Med Sci; 2021 Oct; 51(5):2570-2574. PubMed ID: 34174799
[TBL] [Abstract][Full Text] [Related]
2. Serum anti-GM2 and anti-GalNAc-GD1a ganglioside IgG antibodies are biomarkers for immune-mediated polyneuropathies in cats.
Halstead SK; Jackson M; Bianchi E; Rupp S; Granger N; Menchetti M; Galli G; Freeman P; Kaczmarska A; Bhatti SFM; Brocal J; José-López R; Tipold A; Gutierrez Quintana R; Ives EJ; Liatis T; Nessler J; Rusbridge C; Willison HJ; Rupp A
J Peripher Nerv Syst; 2023 Mar; 28(1):32-40. PubMed ID: 36573790
[TBL] [Abstract][Full Text] [Related]
3. Clinical Features and Neurotologic Findings in Patients With Acute Unilateral Peripheral Vestibulopathy Associated With Antiganglioside Antibody.
Kim KT; Park E; Lee SU; Kim B; Kim BJ; Kim JS
Neurology; 2023 Nov; 101(19):e1913-e1921. PubMed ID: 37748887
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal Fluid Findings in Patients With Autoimmune Encephalitis-A Systematic Analysis.
Blinder T; Lewerenz J
Front Neurol; 2019; 10():804. PubMed ID: 31404257
[TBL] [Abstract][Full Text] [Related]
5. MR Imaging Findings in a Large Population of Autoimmune Encephalitis.
Gillon S; Chan M; Chen J; Guterman EL; Wu X; Glastonbury CM; Li Y
AJNR Am J Neuroradiol; 2023 Jul; 44(7):799-806. PubMed ID: 37385678
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune central nervous system disorders: Antibody testing and its clinical utility.
Gilligan M; McGuigan C; McKeon A
Clin Biochem; 2024 Apr; 126():110746. PubMed ID: 38462203
[TBL] [Abstract][Full Text] [Related]
7. Super refractory status epilepticus secondary to anti-GAD antibody encephalitis successfully treated with aggressive immunotherapy.
Jaafar F; Haddad L; Koleilat N; Sharara-Chami R; Shbarou R
Epilepsy Behav Rep; 2020; 14():100396. PubMed ID: 33305253
[TBL] [Abstract][Full Text] [Related]
8. Anti-NMDAR antibodies, the blood-brain barrier, and anti-NMDAR encephalitis.
Gong X; Wang N; Zhu H; Tang N; Wu K; Meng Q
Front Neurol; 2023; 14():1283511. PubMed ID: 38145121
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Factors in Anti-Neuronal Antibody Positive Patients.
Aydin Ç; Çelik ŞY; İçöz S; Ulusoy C; Gündüz T; Demir GA; Kürtüncü M; Tüzün E
Noro Psikiyatr Ars; 2018; 55(2):189-194. PubMed ID: 30057463
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune Encephalitis.
Leypoldt F; Wandinger KP; Bien CG; Dalmau J
Eur Neurol Rev; 2013; 8(1):31-37. PubMed ID: 27330568
[TBL] [Abstract][Full Text] [Related]
11. A Case Report and Literature Review on Positivity for Multiple Antibodies: Autoimmune Encephalitis in Focus.
Asbeutah S; Alhashime K; Alhamer M
Cureus; 2023 Dec; 15(12):e50393. PubMed ID: 38213350
[TBL] [Abstract][Full Text] [Related]
12. Sequential onset of anti-HU-related paraneoplastic sensory polyneuropathy and limbic encephalitis in pancreatic neuroendocrine tumour: a case report.
Giorelli M; Liuzzi D; Aniello MS; Altomare S; Tarricone NR
Acta Neurol Belg; 2024 Mar; ():. PubMed ID: 38498265
[No Abstract] [Full Text] [Related]
13. Late-onset paraneoplastic encephalitis originates from dopamine 2 receptor autoimmunity associated with prostate adenocarcinoma.
Cai H; Gao H; Chen X; Qin L; Wang R; Yuan Q; Hong Z; Li J; Zhou D; Wang M; Chen Q
Asian J Psychiatr; 2024 Mar; 93():103910. PubMed ID: 38232441
[No Abstract] [Full Text] [Related]
14. Looking Beyond Syndrome-Based Criteria for Autoimmune Encephalitis-The Need for Complementary Neural Antibody-Based Diagnostic Criteria.
Budhram A; Irani SR; Flanagan EP
JAMA Neurol; 2024 Mar; 81(3):227-228. PubMed ID: 38147324
[TBL] [Abstract][Full Text] [Related]
15. GAD-65-Associated Limbic Encephalitis - Early Diagnosis and Course of Disease, Treated with IV Methylprednisolone.
Vegda M; Mehndiratta M
Ann Indian Acad Neurol; 2023; 26(5):785-787. PubMed ID: 38022474
[No Abstract] [Full Text] [Related]
16. Antipsychotics use in autoimmune encephalitis and multiple sclerosis: Impact on hospitalization duration.
Panda PK; Sharawat IK
J Clin Neurosci; 2024 Jul; 125():95-96. PubMed ID: 38759353
[No Abstract] [Full Text] [Related]
17. Response to "Antipsychotics use in autoimmune encephalitis and multiple sclerosis: Impact on hospitalization duration".
Folmsbee SS; Gombar S; Le S
J Clin Neurosci; 2024 Jun; 126():52. PubMed ID: 38833891
[No Abstract] [Full Text] [Related]
18. Autoimmune Encephalitis Consensus Criteria: Lessons Learned From Real-World Practice.
Gelfand JM; Guo CY
Neurol Clin Pract; 2023 Jun; 13(3):e200155. PubMed ID: 37124462
[No Abstract] [Full Text] [Related]
19. Case report: Recreational nitrous oxide abuse triggered peripheral neuropathy possibly through the immune-mediated pathogenesis.
Dong MX; Wang Q; Xu JF; Hu L; Yu Y; Li T
Front Neurol; 2022; 13():1033327. PubMed ID: 36452172
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
